BUSINESS AND LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Jan. 27, 2025	Jan. 31, 2025	Mar. 31, 2025	Mar. 31, 2024	Jan. 29, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reverse stock split	1-for-15 reverse stock split
Common stock, shares issued			2,471,656		15	678,002
Common stock, shares outstanding			2,471,656		15	678,002
Reserve stock split, shares		87,402
Accumulated deficit			$ (108,259,471)			$ (106,074,505)
Net cash used in operating activities			(2,391,582)	$ (2,598,347)
Loss from operations			(2,187,533)	$ (2,477,317)
Cash			4,294,435			$ 2,241,026
Working capital			$ 3,650,434